Key result
Type 2 diabetes is linked to lower telomerase activity and shorter telomeres compared to healthy controls.
Why the study?
The study was conducted to evaluate the relationship between telomerase activity and parameters of carbohydrate metabolism and the vascular wall depending on type 2 diabetes.
Does type 2 diabetes affect telomerase activity and its association with vascular stiffness and chronic inflammation?
Cross-Sectional (n=189)
Does type 2 diabetes affect telomerase activity and its association with vascular stiffness and chronic inflammation?
p-value: p=0.039
Reduced telomerase activity in type 2 diabetes is associated with worsened carbohydrate metabolism, increased systemic inflammation, and greater vascular stiffness, suggesting cellular aging plays an important role in diabetes-associated cardiovascular risk.
T2D-associated lower telomerase activity and shorter telomeres should not yet change practice; leaves open prospective studies on cellular aging and vascular risk.
Aim. To study the relationship between telomerase activity and parameters of carbohydrate metabolism and vascular wall depending on the type 2 diabetes (T2D). Material and methods. The study included 50 patients with T2D and 139 healthy volunteers. All subjects were assessed for carbohydrate metabolism, chronic inflammation (C-reactive protein (CRP), fibrinogen), endothelial dysfunction, carotid intima-media thickness and number of atherosclerotic plaques by duplex scanning, carotid-femoral pulse wave velocity, lymphocyte telomere length and telomerase activity. Results. In T2D patients, telomerase activity was lower (p=0,039), telomeres were shorter (p=0,031) and CRP level was higher (p=0,031) than in patients without T2D. All patients were divided by telomerase activity. T2D patients with low telomerase activity had higher values of CRP ( р =0,016), pulse wave velocity ( р =0,010), carotid intima-media thickness ( р <0,001) and number of atherosclerotic plaques ( р =0,014) than in patients without T2D. There were no significant differences in high telomerase activity group. In the group of patients with/without T2D, there were independent negative relationship between telomerase activity and glycated hemoglobin (p=0,035), fasting plasma glucose (p=0,003), arterial stiffness (p=0,044) and independent positive relationship between telomerase activity and fibrinogen (p=0,027), CRP (p=0,042). Conclusion. Vascular changes, chronic inflammation and cell aging were weightier in patients with T2D. The established relationship between telomerase activity and parameters of carbohydrate metabolism, chronic inflammation and vascular stiffness may indicate the important role of telomerase activity in the development of cardiovascular diseases in T2D patients.
No takes yet. Share an insight, caveat, or question.
Браилова et al. (2019) conducted a cross-sectional in Type 2 Diabetes (n=189). Type 2 diabetes vs. Healthy volunteers without diabetes was evaluated on Telomerase activity (p=0.039). Type 2 diabetes was associated with lower telomerase activity (p=0.039), shorter telomeres (p=0.031), and higher C-reactive protein levels (p=0.031) compared to healthy volunteers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: